CORC

在结果中检索

CORC

浏览/检索结果: 共32条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
A 3D Likelihood Analysis Tool for LHAASO-KM2A data 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Cao, Zhen;  Aharonian, F.;  An, Q.;  Axikegu;  Bai, L. X.
收藏  |  浏览/下载：18/0  |  提交时间：2023/01/13
Phase-separated Ce–Co–O catalysts for CO oxidation 会议论文
作者:  Zhang, Ruishi;  Wang, Junchao;  Zhu, Xiuhui;  Liu, Xiaoyuan;  Liu, Haiyan
收藏  |  浏览/下载：3/0  |  提交时间：2020/12/18
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Safety and Response of an Evans Blue-modified Lu-177-labeled Octreotate in Treatment of Metastatic Neuroendocrine Tumors:A Pilot Prospective Study 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2019-05-01
作者:  Liu, Qingxing;  Cheng, Yuejuan;  Wang, Hao;  Zang, Jie;  Wang, Jingnan
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Safety and response to(177)Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2019-05-01
作者:  Zang, Jie;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang;  Fan, Xinrong
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Safety and dosimetry of Lu-177-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2018-05-01
作者:  Zang, Jie;  Wang, Hao
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace